Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children

Research output: Contribution to journalJournal articleResearchpeer-review

The Bacteroides fragilis group constitute a significant portion of the human gut microbiota and comprise a major proportion of anaerobic bacteria isolated in human infections. We established a baseline of antimicrobial susceptibility rates in the B. fragilis group in the intestinal tract of relatively antibiotic-naive healthy Danish children. From 174 faecal samples collected from children attending day care, 359 non-duplicate isolates were screened for antimicrobial susceptibility. Of these, 0.0%, 1.9%, 5.0% and 21.2% of isolates were intermediate-susceptible or resistant to metronidazole, meropenem, piperacillin/tazobactam and clindamycin, respectively. Eighteen additional studies reporting susceptibility rates in the B. fragilis group bacteria were identified by conducting a literature search. Heterogeneity among results from studies of B. fragilis group antimicrobial susceptibility rates in faecal microbiota exists.

Original languageEnglish
JournalInternational Journal of Antimicrobial Agents
Volume49
Issue number5
Pages (from-to)573-578
ISSN0924-8579
DOIs
Publication statusPublished - 2017

    Research areas

  • Anti-Bacterial Agents/therapeutic use, Bacteroides Infections/drug therapy, Bacteroides fragilis/drug effects, Child, Clindamycin/therapeutic use, Denmark, Drug Resistance, Bacterial, Feces/microbiology, Humans, Metronidazole/therapeutic use, Microbial Sensitivity Tests, Microbiota/drug effects, Penicillanic Acid/analogs & derivatives, Piperacillin/therapeutic use, Surveys and Questionnaires, Thienamycins/therapeutic use

ID: 194917396